Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reninoma: A Rare Cause of Curable Hypertension and Hypokalemia.
Oei L, van den Meiracker AH, Oei EH, Moelker A, van Leenders GJ, Rikken B, Verhagen P, Clahsen-van Groningen MC, van der Wiel HE. Oei L, et al. Am J Med. 2016 Aug;129(8):e131-2. doi: 10.1016/j.amjmed.2016.03.026. Epub 2016 Apr 18. Am J Med. 2016. PMID: 27103051 No abstract available.
AA Amyloidosis and IgG4-Related Disease.
Karim F, Clahsen-van Groningen M, van Laar JA. Karim F, et al. N Engl J Med. 2017 Feb 9;376(6):599-600. doi: 10.1056/NEJMc1614275. N Engl J Med. 2017. PMID: 28177871 No abstract available.
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage.
Mirabito Colafella KM, van Dorst DCH, Neuman RI, Doorn LV, Neves KB, Montezano AC, Garrelds IM, van Veghel R, de Vries R, Uijl E, Clahsen-van Groningen MC, Baelde HJ, van den Meiracker AH, Touyz RM, Visser W, Danser AHJ, Versmissen J. Mirabito Colafella KM, et al. Clin Sci (Lond). 2022 May 13;136(9):675-694. doi: 10.1042/CS20220182. Clin Sci (Lond). 2022. PMID: 35441670 Free PMC article.
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes.
Cruz-López EO, Ren L, Uijl E, Clahsen-van Groningen MC, van Veghel R, Garrelds IM, Domenig O, Poglitsch M, Zlatev I, Rooney T, Kasper A, Nioi P, Foster D, Danser AHJ. Cruz-López EO, et al. Br J Pharmacol. 2023 Jan;180(1):80-93. doi: 10.1111/bph.15955. Epub 2022 Oct 2. Br J Pharmacol. 2023. PMID: 36106615 Free PMC article.
96 results